Perioperative and drug management of patients with rheumatoid arthritis treated with joint replacement.
10.3969/j.issn.1003-0034.2017.11.021
- Author:
Jun LIU
;
Ping ZHEN
;
Sheng-Hu ZHOU
;
Qi TIAN
;
Hui CHEN
;
Jie SHI
;
Wei WANG
;
Xiao-le HE
;
Xu-Sheng LI
1
,
2
Author Information
1. Department of Joint Surgery, General Hospital of Lanzhou Command, Lanzhou 730050, Gansu, China
2. lixush1968@sina.com.
- Publication Type:Journal Article
- Keywords:
Arthritis, rheumatoid;
Arthroplasty, replacement;
Perioperative period
- From:
China Journal of Orthopaedics and Traumatology
2017;30(11):1067-1073
- CountryChina
- Language:Chinese
-
Abstract:
Rheumatoid arthritis (RA) is a most common inflammatory joint disease with direct invasion of joint synovial membrane, cartilage and bone. Currently, although the RA mitigation drugs are being improved continously, but these drugs only can delay the development of joint dysfunction. Total hip arthroplasty or total knee arthroplasty(THA or TKA) has become the only choices for patients with advanced RA, and the joint function and deformity of the patients after surgical treatment can be improved to some extent. However, the progression of RA has a direct effect on the long-term clinical effect of the surgery, and how to improve perioperative management, and combine the joint replacement surgery and drug therapy effectively, have become the focus of attention in clinical doctors. This article intends to summarize the current situation of domestic and foreign management of usage of pre-operative drugs, operation skills, prosthesis selection, postoperative treatment, rehabilitation and complications, so as to improve the long-term efficacy of joint replacement.
